Regulatory Blog

The Regulatory News you Need to Know,Share & Grow

Dec 11, 20231 min read

Singapore's HSA: Post-Industry Consultation Updates on eCTD Implementation in Singapore

On 11th December 2023, Singapore's Health Sciences Authority (HSA) released an update "Post-Industry Consultation Updates on Electronic...

May 4, 20231 min read

Singapore's HSA: Consultation on eCTD Implementation & Risk Classification on IVD

On 2nd May, 2023 Singapore's Health Sciences Authority (HSA) invited the industry to participate in the consultation on eCTD submissions...

Nov 27, 20221 min read

Singapore HSA MedDev: Regulatory Guidelines for Laboratory Developed Tests (LDTs)

On 22nd November, 2022 Singapore's Health Sciences Authority released the final Regulatory Guidelines for Laboratory Developed Tests...

Sep 1, 20221 min read

Singapore HSA: Safety Alert for Finasteride and Potential Risk of Suicidal iIdeation

The Singapore Health Sciences Authority (HSA) published a Safety Alert for Finasteride on 30-August-2022. Suicidal ideation is a known...

Jun 13, 20221 min read

Guidance documents for Therapeutic Products

Health Sciences Authority (HSA) updated its "GUIDANCE ON THERAPEUTIC PRODUCT REGISTRATION IN SINGAPORE" recently, which describes the...

May 8, 20211 min read

Guidance documents for Therapeutic Products (e-labelling) – SINGAPORE

The Therapeutic Products Branch (TPB) finalized guidance on e-labelling of therapeutic products (TPs) in Singapore has been published and...